HMH NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

HMH Holding Inc. Class A Common Stock · Energy · Oil & Gas Equipment & Services

Open interactive chart View report data
Latest close 20.79 USD
-3.4% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is - below the Trend Line and sits at 54.6% of its 52-week range. The latest completed week returned -3.4%, after a 14.9% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is inexpensive relative to peers. The latest news-sentiment score is 52/100. Near-term considerations: earnings are due in 4d.

Setup score 42 out of 100
Latest Close 20.79 USD 31 Jul 2026
1W Return -3.4% latest completed week
4W Return 14.9% short-term follow-through
12W Return -3.3% quarterly tape
Trend Breadth 0.0% 0 of 18 weeks active
Volume Ratio 1.0x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Activity pressure is negative, which weakens the current setup.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • 2 reversal markers appear in the recent smart-money tape.
What to watch next
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -3.4% Latest completed week; four-week move 14.9%. Indicator stack 0/50 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 52/100 12 relevant articles in the latest sentiment read. Event risk 4d Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is - below the Trend Line and sits at 54.6% of its 52-week range. The latest completed week returned -3.4%, after a 14.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.2012-week average 0.19

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.20Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 14.9% over four weeks, -3.3% over 12 weeks, and - over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-3.4%
4W14.9%
12W-3.3%
26W-
52W-
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.00Latest activity-pressure read.
Pressure change-Four-week change in activity pressure.
Leadership-Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 88% Model confidence 84%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength82/100Blend of value, momentum, and quality. Underlying universe rank 19; rank 1 is best.
Value98/100Relative valuation strength. Underlying universe rank 3; rank 1 is best.
Quality30/100Profitability and accounting quality. Underlying universe rank 71; rank 1 is best.
Momentum37/100Medium-term price momentum. Underlying universe rank 64; rank 1 is best.
Growth9/100Revenue and earnings growth. Underlying universe rank 92; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework87/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
6.1x
Price divided by trailing earnings.
Price / sales
0.3x
Market value relative to trailing revenue.
EV / EBITDA
3.6x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
17.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
30.7%
Gross profit retained from each unit of revenue.
Operating margin
14.1%
Operating profit retained from revenue.
Free-cash-flow margin
12.5%
Free cash flow generated from revenue.
Return on invested capital
7.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-2.6%
Latest one-year revenue growth.
EPS growth
-11.3%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
97.2%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment52/100

Weighted news tone is neutral across 12 relevant articles.

2 positive · 10 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings4dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-15.1%Distance below the 52-week high.
13-week volatility7.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher8 of 179 weeks finished lower.
Best week+11.8%Week of 22 May.
Worst week-12.0%Week of 29 May.
Latest week-3.4%Week of 31 Jul.

Shape of recent returns

Strong gains6
Modest gains2
Flat weeks0
Modest losses6
Sharp losses3
Recent vol7.6%13-week weekly-return volatility.
Base vol7.0%52-week weekly-return volatility.
Up/down split8/9Count of positive and negative weeks in the 52-week window.
Average skew6.8% / -4.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape34/100

Trend, activity pressure, participation, and risk combine to a 34/100 tape read.

 Indicator analysis8/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.20; 2 reversal markers Factors61/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 57; Small Cap Core rank 5 SVQF87/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 92.5 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment52/100

Weighted news tone is neutral across 12 relevant articles.

BlackRock (HMH) discloses 6.5% beneficial stake in HMH Holding Class A Insiders50/100

No recent insider transaction evidence is stored.

 Earnings4d

Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202620.79 USD-3.4%-20.38 USD0.00-1.4MOff
24 Jul 202621.52 USD9.5%-20.36 USD0.00-1.1MOff
17 Jul 202619.65 USD-0.8%-20.28 USD0.00-672.6KOff
10 Jul 202619.80 USD9.5%-20.33 USD0.00-705.3KOff
3 Jul 202618.09 USD-9.7%-20.36 USD0.00-1.3MOff
26 Jun 202620.04 USD7.4%-20.54 USD0.00-3.2MOff
19 Jun 202618.66 USD-10.6%-20.58 USD0.00-2.6MOff
12 Jun 202620.87 USD-1.6%-20.76 USD0.00-1.1MOff
5 Jun 202621.22 USD-0.7%-20.74 USD0.00-1.6MOff
29 May 202621.36 USD-12.0%-20.69 USD0.00-1.3MOff
22 May 202624.26 USD11.8%-20.61 USD0.00-1.1MOff
15 May 202621.69 USD0.9%-20.09 USD0.00-803.8KOff
8 May 202621.50 USD1.1%-19.82 USD0.00-951.4KOff
1 May 202621.26 USD5.6%-19.48 USD0.00-1.3MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.